Search results
Results from the WOW.Com Content Network
If a person without a Kidd blood antigen (for example a Jka-Jkb+ patient) receives a Kidd antigen (Jka-antigen for example) in a red blood cell transfusion and forms an alloantibody (anti-Jka); upon subsequent transfusion with Jka-antigen positive red blood cells, the patient may have a delayed hemolytic transfusion reaction as their anti-Jka antibody hemolyzes the transfused Jka-antigen ...
The severity of the transfusion reaction is depended upon amount of donor's antigen transfused, nature of the donor's antigens, the nature and the amount of recipient antibodies. [36] Delayed hemolytic reactions occur more than 24 hours after a transfusion. They usually occur within 28 days of a transfusion.
TA-GvHD can develop two days to six weeks after the transfusion. [4] Typical symptoms include: [4] fever; erythematous maculopapular rash, which can progress to generalised erythroderma; toxic epidermal necrolysis in extreme cases; hepatomegaly; diarrhea; Other symptoms can include cough, abdominal pain, dyspnea and vomiting. [5]
Kidd antibodies are dangerous as they are capable of causing severe acute hemolytic transfusion reactions. They are unique in that they are capable of dropping to low or even undetectable levels after several months following an exposure. [5] Thus, on pre-transfusion testing, an anti-Jka or -Jkb may go undetected.
Post-transfusion purpura (PTP) is a delayed adverse reaction to a blood transfusion or platelet transfusion that occurs when the body has produced alloantibodies to the allogeneic transfused platelets' antigens. These alloantibodies destroy the patient's platelets leading to thrombocytopenia, a rapid decline in platelet count. [1]
An acute hemolytic transfusion reaction (AHTR), also called immediate hemolytic transfusion reaction, is a life-threatening reaction to receiving a blood transfusion. AHTRs occur within 24 hours of the transfusion and can be triggered by a few milliliters of blood. The reaction is triggered by host antibodies destroying donor red blood cells.
Once a woman has antibodies, she is at high risk for a transfusion reaction. [36] For this reason, she must carry a medical alert card at all times and inform all doctors of her antibody status. [citation needed] "Acute hemolytic transfusion reactions may be either immune-mediated or nonimmune-mediated.
Among these, a potentially life-threatening reaction is known as a hemolytic transfusion reaction. This is an immune mediated reaction where recipient antibodies attack donor red blood cell antigen(s), causing hemolysis of donor cells. The reaction may occur during, immediately after, or up to 28 days later.